Early detection and innovative biologic treatment can prevent hospitalizations, improve quality of life, and extend the ...
The 2026 version of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy report has been published. Key ...
The GOLD COPD Update 2026 provides updated guidance on case-finding, disease activity, exacerbation management.
Cost drivers and payer considerations are emphasized for treatment of patients with chronic obstructive pulmonary disease. Jeffrey D. Dunn, PharmD, MBA: Could you summarize the biggest patient cost ...
A Florence woman told us how a modern COPD treatment at Christ Hospital helped her to be able to do things she couldn't do ...
NEW JERSEY (Ivanhoe Newswire) – According to the Centers for Disease Control and Prevention, COPD, or chronic obstructive pulmonary disease was the sixth leading cause of death in the U.S. in 2020.
To keep up with COPD research and care developments, the 2026 Global Initiative for Chronic Obstructive Lung Disease report features two new sections/chapters, two completely revised chapters and ...
She told us her life changed when she sought treatment at Christ Hospital and met Dr. Duane Allen, a pulmonary and critical ...
The procedure is called bronchoscopic lung volume reduction. It involves inserting small valves into the air tubes of the ...
Jul. 1—MORGANTOWN — A new treatment for emphysema is coming to West Virginia. The Zephyr Valve, a treatment classified a medical breakthrough by the Food and Drug Administration, will be offered by ...
Verona Pharma's ensifentrine is a first-in-class, inhaled, dual inhibitor of the enzymes PDE3 and PDE4, targeting both bronchodilation and inflammation. Positive Phase 3 results from the ENHANCE ...
Effective treatment often requires you to take medications to better manage symptoms or stop taking medications if a doctor advises that you no longer need them. Finding the right dosages and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback